NATIONAL SEMICONDUCTOR CORP
10-Q, 1997-12-24
SEMICONDUCTORS & RELATED DEVICES
Previous: MONMOUTH REAL ESTATE INVESTMENT CORP, 10-K, 1997-12-24
Next: NUI CORP, 10-K405, 1997-12-24




            UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                         WASHINGTON, D.C. 20549

                            FORM 10-Q

X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
- --  EXCHANGE ACT OF 1934
For the quarterly period ended November 23, 1997

OR

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934
For the transition period from        to        .
                              --------  --------
Commission File Number: 1-6453


                  NATIONAL SEMICONDUCTOR CORPORATION
                  ---------------------------------- 
        (Exact name of registrant as specified in its charter)

                 DELAWARE                         95-209507
                 --------                         ---------
        (State of incorporation) (I.R.S. Employer Identification Number)

               2900 Semiconductor Drive, P.O. Box 58090
                  Santa Clara, California  95052-8090
                  ------------------------------------
                (Address of principal executive offices)

Registrant's telephone number, including area code:  (408) 721-5000

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. Yes  X  No   .
                                                   ---   ---

Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.


     Title of Each Class             Outstanding at November 23, 1997.
     -------------------             --------------------------------
Common stock, par value $0.50 per share            164,233,744





NATIONAL SEMICONDUCTOR CORPORATION

INDEX



Part I.  Financial Information                            Page No.
                                                          --------

Condensed Consolidated Statements of Operations
  (Unaudited) for the Three Months and Six Months
   Ended November 23, 1997 and November 24, 1996                3

Condensed Consolidated Balance Sheets (Unaudited)
  as of November 23, 1997 and May 25, 1997                      4

Condensed Consolidated Statements of Cash Flows 
 (Unaudited) for the Six Months Ended 
  November 23, 1997 and November 24, 1996                       5

Notes to Condensed Consolidated Financial 
  Statements (Unaudited)                                        6

Management's Discussion and Analysis of Financial
  Condition and Results of Operations                          12

Part II.  Other Information

Legal Proceedings                                              19

Submission of Matters to a Vote of Security Holders            19

Exhibits and Reports on Form 8-K                               20

Signature                                                      22





NATIONAL SEMICONDUCTOR CORPORATION                     
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except per share amounts)

                            Three Months Ended        Six Months Ended
                            ------------------      -------------------
                            Nov. 23,  Nov. 24,      Nov. 23,   Nov. 24,
                              1997      1996          1997       1996
                                     (Restated)               (Restated)
                            --------  --------      --------   --------
Net sales                   $  719.9  $  686.6      $1,376.7   $1,301.9

Operating costs and expenses:
 Cost of sales                 436.4     439.8         832.6      860.0
 Research and development      118.0      97.8         230.1      192.3
 Selling, general and 
  administrative                97.8     120.5         183.7      227.5
Special items:
 Merger costs                   30.0       -            30.0         - 
 Restructuring of operations      -        -              -       256.3
 In-process R&D charge           2.5       -             2.5       10.6
                            --------  --------      --------   --------
   Total operating costs
     and expenses              684.7     658.1       1,278.9    1,546.7
                            --------  --------      --------   --------
Operating income(loss)          35.2      28.5          97.8     (244.8)
Interest income(expense), net    3.4      (2.4)         14.9       (2.8)
Other income, net                1.9       5.0           9.3        4.7
                            --------  --------      --------   --------
Income(loss) before 
  income taxes                  40.5      31.1         122.0     (242.9)
Income tax provision(benefit)   11.6       5.0          30.5      (63.3)
                            --------  --------      --------   --------
Net income(loss)            $   28.9  $   26.1      $   91.5   $ (179.6)
                            ========  ========      ========   ========

Earnings per share: 
         Primary               $ .17     $ .17         $ .54      $(1.16)
         Fully diluted         $ .17     $ .16         $ .54      $(1.16)

Weighted average shares: 
         Primary               169.3     157.5         168.0       154.3
         Fully diluted         169.3     158.6         168.4       154.3
   
Income (loss) used in 
   primary and fully diluted 
   earnings per common share  $ 28.9    $ 26.1        $ 91.5     $(179.6)


See accompanying Notes to Condensed Consolidated Financial Statements

NATIONAL SEMICONDUCTOR CORPORATION 
CONDENSED CONSOLIDATED BALANCE SHEETS  (Unaudited)
(in millions)
                                              Nov. 23,       May 25,
                                                1997          1997  
                                                            (Restated) 
ASSETS                                        --------       --------
Current assets:
  Cash and cash equivalents                   $  734.4       $  897.8
  Short-term marketable investments              118.9           79.6
  Receivables, net                               336.0          281.0
  Inventories                                    246.1          205.8
  Deferred tax assets                            176.7          173.3
  Other current assets                            86.9           99.9
                                              --------       --------
  Total current assets                         1,699.0        1,737.4

Property, plant and equipment                  2,753.9        2,420.4
  Less accumulated depreciation               (1,166.1)      (1,071.4)
                                              --------       --------
  Net property, plant and equipment            1,587.8        1,349.0
Other assets                                     112.3          124.4
                                              --------       --------
Total assets                                  $3,399.1       $3,210.8
                                              ========       ========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
  Short term borrowings and current 
    portion of long-term debt                 $  162.2       $   15.4
  Accounts payable                               274.7          265.5
  Accrued expenses                               321.9          306.8
  Income taxes                                   247.0          238.1
                                              --------       --------
  Total current liabilities                    1,005.8          825.8

Long-term debt                                   306.4          460.5
Deferred income taxes                              9.8           12.1
Other non-current liabilities                     48.0           40.7
                                              --------       --------
  Total liabilities                            1,370.0        1,339.1
                                              --------       --------
Commitments and contingencies                                        

Shareholders' equity:
  Common stock                                    82.1           72.7
  Additional paid-in capital                   1,179.8        1,119.7
  Retained earnings                              767.2          679.3
                                              --------       --------
  Total shareholders' equity                   2,029.1        1,871.7
                                              --------       --------
Total liabilities and shareholders' equity    $3,399.1       $3,210.8
                                              ========       ========

See accompanying Notes to Condensed Consolidated Financial Statements 

NATIONAL SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)                                       Six Months Ended
                                                  --------------------
                                                  Nov. 23,     Nov. 24,
                                                   1997         1996 
                                                              (Restated)
Cash flows from operating activities:             -------      -------
Net income(loss)                                  $  91.5      $(179.6)
Adjustments to reconcile net income(loss)
  with net cash provided by operations:
  Depreciation and amortization                     129.1        131.1
  (Gain)loss on investments                          (6.7)         3.0
  Tax benefit associated with stock options          15.3          4.5
  In-process research and development charge          2.5         10.6
  Loss on disposal of equipment                       6.1          2.4
  Write-down of inventory                              -          15.1
  Non-cash special charges                           30.0        256.3
  Other, net                                          3.6         (1.6)
  Changes in certain assets and liabilities, net:
    Receivables                                     (71.8)       (18.7)
    Inventories                                     (22.8)        31.6
    Other current assets                            (13.4)         5.5
    Accounts payable and accrued expenses              .4        (70.3)
    Current and deferred income taxes                 7.6        (71.3)
    Other liabilities                                 7.3         (1.8)
                                                  -------      -------
Net cash provided by operating activities           178.7        116.8
Cash flows from investing activities:             -------      -------
Purchase of property, plant and equipment          (366.3)      (240.0)
Sale and maturity of marketable investments         909.2        541.4
Purchase of marketable investments                 (948.7)      (524.7)
Sale of investments                                  12.1           - 
Business acquisition, net of cash acquired           (2.8)       (15.4)
Purchase of investments and other, net                (.5)       (12.3)
                                                  -------      -------
Net cash used by investing activities              (397.0)      (251.0)
Cash flows from financing activities:             -------      -------
Issuance of 5.5% convertible subordinated notes,
  less issuance costs                                  -         126.5
Issuance of debt                                       .4         52.2
Repayment of debt                                    (6.4)       (84.7)
Issuance of common stock, net                        43.3         20.5
                                                  -------      -------
Net cash provided by financing activities            37.3        114.5
                                                  -------      -------
Net change in cash and cash equivalents            (181.0)       (19.7)
Adjustment to conform pooling of interests for
  cash and cash equivalents at beginning of year     17.6           -  
Cash and cash equivalents at beginning of period    897.8        486.7
                                                  -------      -------
Cash and cash equivalents at end of period        $ 734.4      $ 467.0
                                                  =======      =======
See accompanying Notes to Condensed Consolidated Financial Statements

Note 1.  Summary of Significant Accounting Policies  
In the opinion of management, the accompanying condensed consolidated 
financial statements contain all adjustments necessary to present fairly 
the financial position and results of operations of National Semiconductor 
Corporation and its subsidiaries ("National" or the "Company").  Interim 
results of operations are not necessarily indicative of the results to be 
expected for the full year. This report should be read in conjunction with 
the consolidated financial statements and notes thereto included in the 
annual report on Form 10-K for fiscal year ended May 25, 1997.

Earnings Per Share:  The Financial Accounting Standards Board recently 
issued Statement of Financial Accounting Standards ("SFAS") No. 128, 
"Earnings Per Share."  SFAS No. 128 requires the presentation of basic 
earnings per share ("EPS") and, for companies with complex capital 
structures or potentially dilutive securities, such as convertible debt, 
options and warrants, diluted EPS.  SFAS No. 128 is effective for annual 
and interim periods ending after December 15, 1997.  As permitted under 
SFAS No. 128, the Company is presenting the following pro forma earnings 
per common share, as if SFAS No. 128 was effective for the periods 
presented:

                              Three Months Ended        Six Months Ended
                              --------------------    --------------------
                              Nov. 23,    Nov. 24,    Nov. 23,    Nov. 24,
                               1997        1996        1997        1996
                              --------    --------    --------    --------
Earnings per common share:
      Basic                     $ .18       $ .17       $ .56       $(1.16)
      Diluted                   $ .17       $ .17       $ .54       $(1.16)

Weighted average common shares:
      Basic                     163.7       155.0       163.0       154.3
      Diluted                   169.3       157.5       168.4       154.3

Financial Instruments:  As more fully described on pages 33-36 in the 
Company's 1997 Annual Report on Form 10-K, the Company utilizes various 
off-balance sheet financial instruments to manage market risks associated 
with fluctuations in certain interest rates and foreign currency exchange 
rates.  The criteria the Company uses for designating an instrument as a 
hedge include the instrument's effectiveness in risk reduction and direct 
matching of the financial instrument to the underlying transaction.  Gains 
and losses on currency forward and option contracts that are intended to 
hedge an identifiable firm commitment are deferred and included in the 
measurement of the underlying transaction.  Gains and losses on hedges of 
anticipated revenue transactions are deferred until such time as the 
underlying transactions are recognized or recognized immediately if the 
transaction is terminated earlier than initially anticipated.  Gains and 
losses on any instruments not meeting the above criteria would be 
recognized in income in the current period.  Subsequent gains or losses on 
the related financial instrument are recognized in income in each period 
until the instrument matures, is terminated or is sold.  Income or expense 
on swaps is accrued as an adjustment to the yield of the related 
investments or debt hedged by the instrument.  Cash flows associated with 
derivative transactions are reported as arising from operating activities 
in the condensed consolidated statements of cash flows.
Pooling Interests Business Combination:  On November 17, 1997, pursuant to 
an Agreement and Plan of Merger, dated as of July 28, 1997, by and among 
National Semiconductor Corporation ("National" or the "Company"), Nova 
Acquisition Corp., a wholly owed subsidiary of the Company ("Sub") and 
Cyrix Corporation ("Cyrix"), the Company acquired all outstanding shares of 
Cyrix common stock through the merger of Sub with and into Cyrix, which 
thereby became a wholly owned subsidiary of the Company.  Cyrix designs, 
develops and markets IBM personal computer software-compatible 
microprocessors for the personal computer industry and is a source of X86 
microprocessors of original design for the personal computer marketplace.  
Under the terms of the agreement, each share of Cyrix common stock was 
exchanged for 0.825 of a share of National common stock.  A total of 16.4 
million shares of National common stock was issued to current holders of 
Cyrix common stock.  In addition, up to 2.7 million shares of National 
common stock may be issued in the future upon exercise of Cyrix employee or 
director stock options or pursuant to Cyrix employee benefit plans and up 
to 2.6 million shares of National common stock may be issued in the future 
upon conversion of Cyrix 5.5% convertible subordinated notes due June 1, 
2001.  

The merger was accounted for as a pooling of interests.  Accordingly, the 
consolidated balance sheets as of November 23, 1997 and May 25, 1997 and 
the consolidated statements of operations for the three months and six 
months ended November 23, 1997 and November 24, 1996, respectively, and the 
consolidated statements of cash flows for the six months ended November 23, 
1997 and November 24, 1996, respectively, include Cyrix.  Since the fiscal 
years for National and Cyrix differ, Cyrix changed its fiscal year-end to 
coincide with National's beginning in fiscal 1998.  Prior year financial 
statements have been restated to include Cyrix and combine National's 
fiscal 1997 with Cyrix's calendar year 1996.  The consolidated balance 
sheet as of May 25, 1997 combines National's consolidated balance sheet as 
of May 25, 1997 with Cyrix's consolidated balance sheet as of December 31, 
1996.  The consolidated statements of operations for the three months and 
six months ended November 24, 1996 and the consolidated statement of cash 
flows for the six months ended November 24, 1996 combine National's 
consolidated statements of operations for the three months and six months 
ended November 24, 1996 and the consolidated statement of cash flows for 
the six months ended November 24, 1996 with Cyrix's consolidated statements 
of operations for the three months and six months ended June 30, 1996 and 
the consolidated statement of cash flows for the six months ended June 30, 
1996.  The results of operations for the period January 1, 1997 through May 
25, 1997 for Cyrix which included net sales of $84.6 million, total 
operating costs and expenses of $84.4 million, net loss of $0.6 million and 
an increase in capital from the issuance of common stock of $1.3 million, 
have been recorded as an adjustment to shareholders' equity as of May 25, 
1997.

There were no transactions between Cyrix and National prior to the 
combination, and no adjustments were necessary to conform the accounting 
policies of the combining companies.  Certain amounts for Cyrix have been 
reclassified to conform with the financial statement presentation followed 
by National.

The following table summarizes the results of operations previously 
reported by the separate companies and the combined amounts presented in 
the accompanying consolidated financial statements based on the interim 
period ending November 23, 1997 which represents the closest interim period 
to the date the merger was consummated:

                   Three Months Ended            Six Months Ended
                   ------------------            ----------------
                  Nov. 23,    Nov. 24,          Nov. 23,    Nov. 24,
                    1997        1996              1997        1996
                  --------    --------          --------    --------

Net sales:
  National        $  640.3    $  661.5          $1,241.1    $1,227.6
  Cyrix               79.6        25.1             135.6        74.3
                  --------    --------          --------    --------
  Combined        $  719.9    $  686.6          $1,376.7    $1,301.9
                  ========    ========          ========    ========

Net income:
  National        $   50.0    $   42.5          $  120.1    $ (165.1)
  Cyrix              (21.1)      (16.4)            (28.6)      (14.5)
                  --------    --------          --------    --------
  Combined        $   28.9    $   26.1          $   91.5    $ (179.6)
                  ========    ========          ========    ========

In connection with the merger, the Company recorded a one-time charge of 
$30.0 million related to certain merger and related expenses in its second 
quarter ended November 23, 1997.  These expenses primarily include 
transaction fees for investment bankers, attorneys, and accountants; 
financial printing costs; and costs associated with the elimination of 
duplicate facilities and operations.  The Company also expects to pay 
approximately $10.1 million in retention bonuses to certain Cyrix 
employees.  These amounts will be expensed to operations ratably over the 
employees' service period.  The service period varies by employee, but is 
generally 18 months following the consummation of the merger. 


Note 2.  Components of Inventories
The components of inventories were: 
(in millions)                                    Nov. 23,   May 25,
                                                   1997      1997
                                                 -------    -------
Raw materials                                    $  23.2    $  25.0
Work in process                                    157.1      133.0
Finished goods                                      65.8       47.8
                                                 -------    -------
     Total inventories                           $ 246.1    $ 205.8
                                                 =======    =======

Note 3.  Other income, net
Components of other             Three Months Ended    Six Months Ended
income,net were:                ------------------   ------------------
(in millions)                   Nov. 23,  Nov. 24,   Nov. 23,  Nov. 24,
                                  1997      1996       1997      1996   
                                --------  --------   --------  --------
Net intellectual property income $   1.9   $   3.4    $   2.6   $   6.1
Gain(loss)on investments, net         -         -         6.7      (3.0)
Other                                 -        1.6         -        1.6
                                 -------   -------    -------   -------
     Total other income, net     $   1.9   $   5.0    $   9.3   $   4.7
                                 =======   =======    =======   =======


Note 4.  Statement of Cash Flows Information
(in millions)     
                                                  Six Months Ended
                                                 ------------------
                                                 Nov. 23,   Nov. 24,
                                                   1997       1996
                                                 --------   --------
Supplemental disclosure of cash flow
  information:     
Cash paid(received) for:
    Interest                                     $  17.4    $  12.7
    Interest on tax settlements                       .1         .1
    Income taxes                                    12.2        4.4

Supplemental schedule of non-cash investing
  and financing activities:  
  Issuance of stock for employee benefit plans   $   2.5    $   3.2
  Tax benefit for employee stock option plans       15.3        4.5
  Retirement of treasury stock                        -          - 
  Unrealized gain (loss) on available-for-sale
    securities                                      (3.0)      (4.7)
  Unearned compensation charge relating to
    restricted stock issuance                         -         8.1
  Amortization of unearned compensation charge       7.3         .9
  Restricted stock cancellations   	             0.2         -

Note 5.  Restructuring of Operations
In fiscal 1997, the Company reorganized its operating structure to comprise 
the Analog Group, the Communications and Consumer Group, and the Personal 
Systems Group to enhance the focus and support of the Company's strength in 
analog and mixed signal technology.  The Company also announced a planned 
comprehensive realignment of its manufacturing facilities designed to 
accelerate its production transition to manufacturing 8-inch wafers with 
0.35-micron circuit geometries, reduce costs and rationalize production 
flows.  As a result of these actions, the Company recorded a net $134.2 
million of restructure charges in fiscal 1997.


In connection with the planned realignment of its manufacturing facilities, 
the Company also expects to pay approximately $7.2 million in retention 
bonuses to certain Santa Clara employees as a result of the planned closure 
of the 5- and 6-inch wafer fabrication facilities in Santa Clara.  These 
amounts will be expensed to operations ratably over the employees' service 
period up through the close of the facilities.

Amounts paid as a result of work force reduction actions that occurred in 
the first six months of fiscal 1998 related to these restructuring 
activities were immaterial.  Included in accrued liabilities at November 
23, 1997 is $65.2 million related to remaining costs, including severance 
for those previously announced restructuring activities that are not yet 
completed.


Note 6 - Debt
Under the terms of the Indenture for the Cyrix 5.5% convertible 
subordinated notes, the merger with Cyrix constituted a change of control.  
As a result, each holder of the Cyrix convertible subordinated notes 
("securities") has the right to require the Company to repurchase all of 
the outstanding securities or any portion of the principal amount thereof 
that is equal to $5,000 or any integral multiple of $1,000 in excess 
thereof on January 12, 1998 at a purchase price to be paid in cash equal to 
100% of the principal amount of the securities to be repurchased plus 
interest accrued to the repurchase date.  Due to the rights of the security 
holders, the Company may be required to pay up to $126.5 million to 
security holders in the third quarter of fiscal 1998.  Accordingly, the 
Company has classified the entire outstanding principle balance as of 
November 23, 1997 as current. There are no restrictions on Cyrix's ability 
to transfer funds to the Company in the form of cash dividends, loans or 
advances. 

In connection with the foregoing securities, the following separate 
summarized financial information for Cyrix is being presented pursuant to 
Rule 1-02 (bb) of Regulation S-X of the Securities and Exchange Act:  

                         Three Months Ended             Six Months Ended
                        --------------------          --------------------
Cyrix                   Nov. 23,    Nov. 24,          Nov. 23,    Nov. 24,
Results of Operations     1997        1996              1997        1996
- ---------------------   --------    --------          --------    --------

Net sales               $   79.6    $   25.1          $  135.6    $   74.3
Gross profit            $    4.3    $   (1.3)         $   15.4    $   21.6
Net income(loss)        $  (21.1)   $  (16.4)         $  (28.6)   $  (14.5)

                        Nov. 23,     May 25,          
Balance Sheet             1997        1997            
- -------------           --------    --------          

Current assets          $  210.1    $  184.8                
Non-current assets      $   82.3    $  111.9                
Current liabilities     $   41.2    $   34.4                
Non-current liabilities $  135.5    $  139.4

Note 7.  Contingencies
In fiscal 1997, the Company received notices of assessment totaling 
approximately $59.2 million from the Malaysian Inland Revenue Department 
relating to the Company's manufacturing operations in Malaysia.  The issues 
giving rise to the assessments relate to intercompany transfer pricing, 
primarily for fiscal 1993.  The Company believes the assessments are 
without merit and has been contesting them administratively.  The Company 
believes that adequate accruals have been recorded for the years in 
question.



MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


Overview   On November 17, 1997, Nova Acquisition Corp., a subsidiary of 
National Semiconductor Corporation ("National" or the "Company") merged 
with Cyrix Corporation ("Cyrix")and Cyrix became a wholly owned subsidiary 
of the Company.  Cyrix designs, develops and markets IBM personal computer 
software-compatible microprocessors for the personal computer industry and 
is a source of X86 microprocessors of original design for the personal 
computer marketplace.  The Company believes that access to Cyrix's X86 
microprocessor cores and the combination of technologies resulting from the 
merger will provide a major step in achieving its system-on-a-chip strategy 
to develop certain highly integrated, application specific semiconductor 
products.  The discussion that follows includes results for Cyrix.

For the second quarter and first six months of fiscal 1998, the Company 
recorded net sales of $719.9 million and $1,376.7 million, respectively, a 
4.8 percent and 5.7 percent increase from net sales of $686.6 million and 
$1,301.9 million for the comparable periods of fiscal 1997.  Net income was 
$28.9 million and $91.5 million for the second quarter and first six months 
of fiscal 1998, respectively, compared to net income of $26.1 million and a 
net loss of $179.6 million for the second quarter and first six months of 
fiscal 1997, respectively.  Net income for the second quarter and first six 
months of fiscal 1998 includes a one-time charge of $30 million related to 
certain merger and related expenses.  These expenses primarily include 
transaction fees for investment bankers, attorneys, and accountants; 
financial printing costs; and costs associated with the elimination of 
duplicate facilities and operations.  Net income for the second quarter and 
first six months of fiscal 1998 also includes a one-time charge of $2.5 
million for in-process research and development ("R&D") related to the 
acquisition of Future Integrated Systems, Inc. ("FIS"), a supplier of 
graphics hardware and software products for the personal computer market.  
The Company believes the FIS acquisition will accelerate its efforts 
towards providing system-on-a-chip solutions for the personal computer 
market.  The operating results for the second quarter and first six months 
of fiscal 1997 include the Fairchild Semiconductor ("Fairchild") 
operations, which the Company divested in the fourth quarter of fiscal 
1997.

The Company has presented management's discussion and analysis of financial 
condition and results of operations to also include comparison to fiscal 
1997 of the Company's core business without Fairchild.  The Company's core 
business includes the Analog Group, the Communications and Consumer Group, 
and the Personal Systems Group, which includes Cyrix.  The following 
selected financial information is presented for such comparative purposes.  
All periods presented below exclude Special Items and for the first six 
months ended November 24, 1996 also excludes the effect of certain one-time 
charges included in cost of sales.


        Three Months Ended
- --------------------------------- 
(in millions)                       Nov. 23, 1997     Nov. 24, 1996
                                    -------------   -----------------
                                           Core       Core     Total 
                                         Business   Business  Company
                                         --------   --------  -------
Net sales                                  $719.9     $532.6   $686.6
Gross profit                               $283.5     $193.3   $246.8
Gross margin                                39.4%      36.3%    35.9%
Research and development                   $118.0      $93.4    $97.8
Selling, general and administrative         $97.8     $100.0   $120.5
Net income                                  $28.9       $5.4    $26.1
        
        Six Months Ended
- ---------------------------------
(in millions)                       Nov. 23, 1997     Nov. 24, 1996
                                    -------------   -----------------
                                           Core       Core     Total 
                                         Business   Business  Company
                                         --------   --------  -------
Net sales                                $1,376.7   $1,015.3 $1,301.9
Gross profit                               $544.1     $378.2   $441.9
Gross margin                                39.5%       37.3%   33.9%
Research and development                   $230.1     $183.4   $192.3
Selling, general and administrative        $183.7     $188.3   $227.5  
Net income (loss)                           $91.5      $10.1  $(179.6)  


Sales	Sales of $719.9 million and $1,376.7 million for the second quarter 
and first six months of fiscal 1998 for National's core business described 
above increased 35.2 percent and 35.6 percent, respectively, compared to 
sales of $532.6 million and $1,015.3 million for the same periods of fiscal 
1997 for the Company's core business. These increases reflect growth in 
sales from Cyrix microprocessor products of 255 percent and 46.2 percent 
for the respective corresponding periods as measured over sales for Cyrix's 
second quarter and first six months ended June 30, 1996. Excluding the 
effect of Cyrix product sales, sales for  National's core business for the 
second quarter and first six months of fiscal 1998 grew 26.2 percent and 
31.9 percent, respectively.  This growth is led by sales for analog 
products which grew 34.7 percent and 43.2 percent for the second quarter 
and first six months of fiscal 1998 over the same periods of fiscal 1997. 
The increase in sales also reflects the continued growth in sales for wide 
area network products, including wireless communication products, local 
area network ("LAN") products and personal computer products, which grew 
35.1 percent, 20.4 percent and 20.1 percent, respectively, for the second 
quarter of fiscal 1998 over the comparable quarter of fiscal 1997 and 27.1 
percent, 32.7 percent and 25.7 percent, respectively, year over year. Sales 
increases for all of these product areas were the result of increased unit 
shipments.  Overall, increased unit shipments resulted in increased sales 
despite some price declines, particularly in the LAN Ethernet products.


Gross Margin   Gross margin as a percentage of sales rose to 39.4 percent 
and 39.5 percent for the second quarter and first six months of fiscal 
1998, respectively, compared to 35.9 percent and 33.9 percent for the same 
periods of fiscal 1997. With respect to the Company's core business, gross 
margin for fiscal 1998 reflects an improvement over gross margin of 36.3 
percent and 37.3 percent for the second quarter and first six months of 
fiscal 1997, respectively.  The Company's core business for fiscal 1997 
excludes the effect of Fairchild and for the first six months of fiscal 
1997, also exclude certain one-time charges of $18.7 related to the 
Company's reorganization in the first quarter of fiscal 1997.  The primary 
factor contributing to gross margin improvement was increased factory 
utilization which reached 86 percent in the second quarter and first six 
months of fiscal 1998 as new orders remained strong.  The Company also 
achieved manufacturing efficiencies from improvements in manufacturing 
yield and in particular, process cycle time, that offset start-up costs in 
the its new 8-inch wafer fabrication facility in Maine. 


Research and Development   R&D expenses for the second quarter and first 
six months of fiscal 1998 increased by 23.2 percent and 14.6 percent, 
respectively, from the comparable periods of fiscal 1997.  Excluding the 
effect of a $2.5 million special charge for in-process R&D related to the 
acquisition of FIS in the second quarter and first six months of fiscal 
1998 and excluding the effect of Fairchild for fiscal 1997 and a $10.6 
million special charge for in-process R&D related to the acquisition of the 
PicoPower division of Cirrus Logic Inc. from the first six months of fiscal 
1997, R&D expenses for the second quarter and first six months of fiscal 
1998 increased by 26.3 percent and 25.5 percent over R&D expenses for the 
Company's core business.  Although the Company increased its investment in 
R&D for the second quarter and first six months of fiscal 1998 over the 
same periods of fiscal 1997 for the core business, R&D expenses as a 
percentage of sales for the second quarter and first six months of fiscal 
1998 decreased to 16.4 percent and 16.7 percent from 17.5 percent and 18.1 
percent for the same fiscal 1997 periods, as the increase in sales exceeded 
the increase in R&D expenses.  Overall, the increase in R&D expenses 
reflects the Company's accelerated investment in advanced submicron CMOS 
process technology that is part of the Company's focus on state-of-the-art 
process technology, which has been set as one of the Company's strategic 
imperatives.  The increase also reflects the Company's continuing 
investment in the development of new analog and mixed signal based products 
for applications in the personal systems, communications and consumer 
markets.


Selling, General and Administrative Selling, general and administrative 
("SG&A") expenses for the second quarter and first six months of fiscal 
1998 decreased by 18.8 percent and 19.3 percent from the second quarter and 
first six months of fiscal 1997. The decrease reflects the effect of 
centralization initiatives implemented in connection with the Company's 
fiscal 1997 reorganization that have reduced the Company's infrastructure.  
Excluding the Fairchild SG&A expenses from the second quarter and first six 
months of fiscal 1997, SG&A expenses for fiscal 1998 decreased by 2.2 
percent and 2.4 percent for the second quarter and first six months, 
respectively, for the Company's core business.  While SG&A expenses 
remained relatively flat with the comparable period of fiscal 1997, SG&A 
expenses as a percentage of sales for the Company's core business decreased 
to 13.6 percent and 13.3 percent from 18.8 percent and 18.5 percent for the 
same periods of fiscal 1997 for the core business primarily due to the 
growth in sales by 35.6 percent.  


Interest Income and Interest Expense   Net interest income was $3.4 million 
and $14.9 million for the second quarter and first six months of fiscal 
1998 compared to net interest expense of $2.4 million and $2.8 million in 
the second quarter and first six months of fiscal 1997.  The increase was 
attributable to the combination of increased interest earned on higher cash 
balances offset by less interest expense from lower debt balances.  In 
addition, the Company capitalized $5.4 million of interest associated with 
capital expansion projects for first six months of fiscal 1998 of which all 
was recorded in the first quarter, compared to $3.8 million for the same 
period of fiscal 1997.


Other Income, Net   Other income, net was $1.9 million and $9.3 million for 
the second quarter and first six months of fiscal 1998 compared to $5.0 
million and $4.7 million for the second quarter and first six months of 
fiscal 1997.  For the second quarter of fiscal 1998, other income, net 
included a $1.8 million gain from the sale of stock from the Company's 
investment holdings that was offset by a $1.8 million write down to fair 
market value of other investments and $1.9 million of net intellectual 
property income. This compares to $1.6 million of dividend income from an 
investment holding plus $3.4 million of net intellectual property income 
during the second quarter of fiscal 1997.  Other income, net for the first 
six months of fiscal 1998 included a $6.7 million net gain from the sale of 
stock from the Company's investment holdings and $2.6 million of net 
intellectual property income during the same period in fiscal 1997.  This 
compares to other income, net for the first six months of fiscal 1997 which 
includes $1.6 million of dividend income from an investment holding, $6.1 
million of net intellectual property income offset by a $3.0 million net 
loss on investments primarily attributable to the write down of an 
investment to net realizable value.


Income Tax Expense   Income tax expense for fiscal 1998 is based on the 
Company's expected effective tax rate of 25 percent. 


Financial Condition   During the first six months of fiscal 1998, cash and 
cash equivalents decreased $181.0 million compared to a $19.7 million 
decrease for the first six months of fiscal 1997.  The decrease for fiscal 
1998 was primarily the result of the Company's continued investment in 
property, plant and equipment of $366.3 million and net purchases of 
marketable investments of $39.5 million that offset cash flows generated 
from operating activities of $178.7 million and proceeds from issuance of 
common stock of $43.3 million.  This compares to $240.0 million of 
investment in property, plant and equipment offset by $116.8 million of 
cash generated from operating activities and $114.5 million of cash 
generated from financing activities for the first six months of fiscal 
1997.  For fiscal 1997, cash flows from financing activities included 
proceeds of $20.5 million from the issuance of common stock, $126.5 million 
from convertible subordinated notes issued by Cyrix and $50.2 million from 
the utilization of the Company's equipment loan, which were offset by $84.7 
million in general debt repayments. 

Under the terms of the Indenture for the Cyrix 5.5% convertible 
subordinated notes, the merger with Cyrix constituted a change of control.  
As a result, each holder of the Cyrix convertible subordinated notes 
("securities") has the right to require the Company to repurchase all of 
the outstanding securities or any portion of the principal amount thereof 
that is equal to $5,000 or any integral multiple of $1,000 in excess 
thereof on January 12, 1998 at a purchase price to be paid in cash equal to 
100% of the principal amount of the securities to be repurchased plus 
interest accrued to the repurchase date.  Due to the rights of the security 
holders, the Company may be required to pay up to $126.5 million to 
security holders in the third quarter of fiscal 1998.  Accordingly, the 
Company has classified the entire outstanding principle balance as of 
November 23, 1997 as current. There are no restrictions on Cyrix's ability 
to transfer funds to the Company in the form of cash dividends, loans or 
advances. 

Management foresees continuing significant cash outlays for plant and 
equipment throughout fiscal 1998.  The capital expenditure level for fiscal 
1998 is expected to be slightly higher than the fiscal 1997 level.

Existing cash and investment balances, together with existing lines of 
credit, are expected to be sufficient to finance planned fiscal 1998 
capital investments as well as any payments related to the repurchase of 
the 5.5% convertible subordinated notes.


Outlook   The statements contained in this Outlook and in the Financial 
Condition section of Management's Discussion and Analysis are forward 
looking based on current expectations and management's estimates.  Actual 
results may differ materially from those set forth in such forward looking 
statements.  In addition to the risk factors discussed in the Outlook and 
Financial Condition sections of Management's Discussion and Analysis of 
Financial Condition and Results of Operations on pages 23 through 25 of the 
Company's 1998 Annual Report on Form 10-K filed with the Securities and 
Exchange Commission, the following factors may also affect the Company's 
operating results for fiscal 1998.

As business conditions for the semiconductor industry improved in calendar 
1997, the Company experienced significant improvement in new order rates 
for fiscal 1998.  New orders were strong and grew through the second 
quarter.  Although the Company expects this trend to continue through 
fiscal 1998, there is a risk that the improvement in new order rates may be 
temporary. If the rate of new orders does not continue to increase, the 
Company may be unable to sustain the level of revenue growth expected for 
fiscal 1998 and operating results will be unfavorably affected. 
Additionally, the rate of orders and product pricing may be affected by 
continued and increasing competition and by growth rates in the personal 
computer and networking industries.  In the winter quarter, the Company has 
traditionally faced the risk of a drop in order rates in the personal 
computer industry after the Christmas season has ended. 

Although the Company has not experienced any unfavorable effect from the 
current economic and currency uncertainty in the Asia Pacific region, the 
Company is cautiously monitoring the backlog and future orders from its 
customers in that region to evaluate any possible impact on shipments, as 
well as reviewing the credit position of these customers.  However, there 
can be no assurance that this situation will not adversely affect the 
Company's business in the future.

In November 1997, the Company completed the merger of its subsidiary with 
Cyrix.  The Company believes the technologies and capabilities of Cyrix and 
National are complementary and the separate operations compatible, however, 
the integration of the two companies' operations may have an unfavorable 
impact on future operating results if the Company encounters unforeseen 
obstacles or is unable to successfully execute its integration plan. Other 
factors related to the Cyrix business that may affect the Company's results 
of operations include the following:  Cyrix is a small competitor in the 
personal computer market for socket-seven compatible microprocessor 
products where other large competitors such as Intel Corporation could 
significantly influence the price of products.  Cyrix is dependent on 
"quarterly turns orders", which are orders that book and bill in the same 
quarter and may result in lack of forward visibility in new orders.  Cyrix 
is currently reliant on third-party manufacturers for the production of its 
products and this may result in unpredictable manufacturing yields.  The 
lack of control over the yield distribution of acceptable speed levels on 
Cyrix microprocessor products may unfavorably impact product availability.

The new 8-inch wafer fabrication facility in Maine that the Company 
anticipated to bring on-line in early fiscal 1998 is currently scheduled to 
begin ramping production in the third quarter.  The Company expects to 
incur additional start-up manufacturing costs associated with ramping the 
production capability in that facility.  Delays in the start of ramped 
production may unfavorably impact gross margin for fiscal 1998.  Although 
the Company does not anticipate a seasonal impact on wafer fab capacity 
utilization during the winter quarter due to shutdowns and  vacations at 
its manufacturing facilities during the holiday season, the Company still 
faces the risk that the Thanksgiving, Christmas and New Year holidays, 
including the Chinese New Year, will have an impact on production levels 
during the third quarter.  Unless wafer fab capacity utilization can be 
held at a level comparable with the second quarter, gross margin will be 
unfavorably affected. 

The Company expects to continue to pursue opportunities to acquire key 
technology to augment its technical capability or to achieve faster time to 
market as alternatives to internally developing such technology.  In 
addition to the Company's regular involvement in  licensing arrangements 
and joint venture relationships, these opportunities are expected to 
include business acquisitions.  With such acquisitions, there is the risk 
that future operating performance may be unfavorably impacted due to 
acquisition related costs, such as but not limited to, in-process R&D 
charges, added R&D expenses, lower gross margins from acquired product 
portfolios and restructure costs associated with duplicate facilities. 

The Company has received notices of tax assessments from certain 
governments of countries within which the Company operates.  There can be 
no assurance that these governments or other government entities will not 
serve future notices of assessments on the Company, or that the amounts of 
such assessments and the failure of the Company to favorably resolve such 
assessments would not have a material adverse effect on the Company's 
financial condition or results of operations.  In addition, the Company is 
engaged in administrative tax appeals with the IRS and the Company's tax 
returns for certain years are under examination in the U.S. and Malaysia.  
There can be no assurance that the ultimate outcome of the tax appeals or 
tax examinations would not have a material adverse effect on the Company's 
future financial condition or results of operations.

The forward looking statements discussed or incorporated by reference in 
this outlook section involve a number of risks and uncertainties.  Other 
risks and uncertainties include, but are not limited to, the general 
economy, regulatory and international economic conditions, the changing 
environment of the semiconductor industry, competitive products and 
pricing, growth in the personal computer and communications industries, the 
effects of legal and administrative cases and proceedings, and such other 
risks and uncertainties as may be detailed from time to time in the 
Company's SEC reports and filings.

PART II.  OTHER INFORMATION


Item 1.  Legal Proceedings
- --------------------------

Except as noted below, there have been no material developments in the legal 
proceedings reported in Item 3 in the Company's Annual Report on Form 10-K 
for the year ended May 25, 1997:

On November 12, 1997, a class action lawsuit was filed in California State 
Court against the Company, Cyrix Corporation ("Cyrix"), Cyrix's Board of 
Directors and Cyrix's Chief Executive Officer by Goodman Epstein, 
individually and on behalf of Cyrix stockholders.  The complaint alleges 
that the named individual defendants breached their fiduciary duty to the 
stockholders of Cyrix in connection with their approval of Cyrix's merger 
with a subsidiary of the Company and that the Company further aided and 
abetted the alleged breach of fiduciary duty.  The complaint seeks certain 
declaratory and injunctive relief, an accounting to the plaintiff and 
members of the class for the damages alleged to have been suffered, costs 
and fees.  An ex parte application filed by plaintiffs for a temporary 
restraining order, preliminary injunction and an expedited discovery order 
was scheduled to be heard on November 14, 1997, but was subsequently dropped 
by plaintiffs and was not heard.  The Company believes the claims brought by 
plaintiffs are without merit and intends to contest the action vigorously.


Item 4.  Submission of Matters to Vote of Security Holders
- ----------------------------------------------------------

1.  (a)     The Registrant's Annual Meeting was held on September 26, 1997.

    (b)     The following directors were elected at the Meeting:

                                                       AUTHORITY
            DIRECTOR                 FOR               WITHHELD
            --------                ------------       ---------       
            Brian L. Halla          126,749,646         549,531        
            Gary P. Arnold          126,764,820         534,357        
            Robert Beshar           126,728,132         571,045        
            Modesto A. Maidique     126,779,702         519,475
            Edward R. McCracken     126,806,976         492,201
            J. Tracy O'Rourke       126,794,737         504,440
            Charles E. Sporck       126,739,516         559,661
            Donald E. Weeden        126,767,048         532,129

    (c)     Other matters voted on at the Meeting were the following:

           (i)    To approve amendments to the Director Stock Plan:

                  FOR:         92,694,238
                  AGAINST:     34,070,197
                  ABSTAIN:        534,742

           (ii)   To approve the adoption of the Director Stock Option Plan:

                  FOR:         74,227,933
                  AGAINST:     52,523,111
                  ABSTAIN:        548,133

(a)  The special meeting of Cyrix Corporation on the merger of Cyrix
    with a subsidiary of the Company was held on November 17, 1997.

(b)  The vote to approve the merger agreement was as follows:
                  FOR:         11,663,903
                  AGAINST:         52,727
                  WITHELD:         19,198


Item 6.   Exhibits and Reports on Form 8-K
- ------------------------------------------

(a)  Exhibits
      --------

2.1 Agreement and Plan of Merger by and among National Semiconductor 
Corporation, Nova Acquisition Corporation and Cyrix Corporation dated 
as of July 28, 1997 (incorporated by reference from the Exhibits to 
the 10-K for the fiscal year ended May 25, 1997 filed August 6, 1997).

3.1  Second Restated Certificate of Incorporation of the Company as amended 
(incorporated by reference from the Exhibits to the Company's 
Registration Statement on Form S-3 Registration No. 33-52775, which 
became effective March 22, 1994); Certificate of Amendment of 
Certificate of Incorporation dated September 30, 1994 (incorporated by 
reference from the Exhibits to the Company's Registration Statement on 
From S-8 Registration No. 333-09957, which became effective August 12, 
1996).

3.2  By Laws of the Company (incorporated by reference from the Registration 
Statement on Form S-8 Registration No. 333-36733, which became 
effective September 30, 1997).

4.1  Rights Agreement (incorporated by reference from the Exhibits to the 
Company's Registration Form 8-A filed August 10, 1988).  First 
Amendment to the Rights Agreement (incorporated by reference from the 
Exhibits to the Amendment No. 1 to the Company's Registration 
Statement on Form 8-A filed December 11, 1995).  Second Amendment to 
the Rights Agreement dated as of December 17, 1996 (incorporated by 
reference from the Exhibits to the Company's Amendment No. 2 to the 
Registration Statement on Form 8-A filed January 17, 1997).

4.2  Form of Common Stock Certificate (incorporated by reference from the 
Exhibits to the Company's Registration Statement on Form S-3 
Registration No. 33-48935, which became effective October 5, 1992).

4.3  Indenture dated as of September 15, 1995 (incorporated by reference 
from the Exhibits to the Company's Registration Statement on Form S-3 
Registration No. 33-63649, which became effective November 6, 1995).

4.4 Registration Rights Agreement dated as of September 21, 1995 
(incorporated by reference from the Exhibits to the Company's 
Registration Statement on Form S-3 Registration No. 33-63649, which 
became effective November 6, 1995).

4.5  Form of Note (incorporated by reference from the Exhibits to the 
Company's Registration Statement on Form S-3 Registration No. 33-63649, 
which became effective November 6, 1995).

4.6  Indenture dated as of May 28, 1996 between Cyrix and Bank of Montreal
Trust Company as Trustee (incorporated by reference from the Exhibits to
Cyrix's Registration Statement on Form S-3 Registration No. 333-10669, 
which became effective August 22, 1996).

4.7  Registration Rights Agreements dated as of May 28, 1996 between Cyrix
and Goldman, Sachs & Co. (incorporated by reference from the Exhibits 
to Cyrix's Registration Statement on Form S-3 Registration No. 333-10669, 
which became effective August 22, 1996).

11.0 Computation of Earnings Per Share-Assuming Full Dilution 

27.0 Financial Data Schedule

(b)  Reports on Form 8-K

      A report on Form 8-K was filed November 14, 1997 announcing that a 
class action lawsuit had been filed on November 12, 1997 by a 
purported stockholder of Cyrix Corporation ("Cyrix").  The complaint 
names both National Semiconductor Corporation ("NSC") and Cyrix as 
defendants, as well as the board of directors and chief executive 
officer of Cyrix and alleges that the Cyrix board breached its 
fiduciary duties in connection with its approval of the merger of 
Cyrix with NSC's subsidiary and that NSC aided and abetted the alleged 
breach of fiduciary duty.  No financial statements were filed with the 
Form 8-K.



SIGNATURE
- ---------


   Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.



                                   NATIONAL SEMICONDUCTOR CORPORATION



Date:  December 24, 1997             /s/ Richard D. Crowley, Jr.
                                     ----------------------------------
                                     Richard D. Crowley, Jr.
                                     Vice President and Controller
                                     Signing on behalf of the registrant
                                     and as principal accounting officer 


                                                              Exhibit 11.0

NATIONAL SEMICONDUCTOR CORPORATION                        
ADDITIONAL FULLY DILUTED CALCULATION OF EARNINGS PER SHARE(1)
(in millions, except per share amounts)

                            Three Months Ended        Six Months Ended
                            ------------------      --------------------
                            Nov. 23,   Nov. 24,      Nov. 23,   Nov. 24,
                              1997       1996          1997       1996
                            --------  --------      --------    --------
Net income(loss), as        $   28.9  $   26.1      $   91.5    $ (179.6)
 reported and used for
 primary earnings per share
Adjustment for interest on
 convertible notes               4.5       2.4           9.0         4.8
                            --------  --------      --------    --------
Net income (loss) used for
 fully diluted earnings 
 per share                      33.4      28.5         100.5      (174.8)(2)
                            ========  ========      ========    ========
Number of shares:
Weighted average common
  shares outstanding           163.7     155.0         163.0       154.3

Weighted average common
  equivalent shares, net of 
  tax benefit                    5.6       2.5           5.0         2.1 (3)
                            --------   -------      --------    --------
Weighted average common and
  common equivalent shares
  for primary earnings per
  share                        169.3     157.5         168.0       156.4 

Additional weighted average
  common equivalent shares
  assuming full dilution          -        1.1           0.4         0.5 (3)

Shares issuable from 
  assumed conversion of 
  convertible notes              8.6       6.9           8.6         6.5
                            --------   -------      --------    --------
Weighted average common and
  common equivalent shares 
  assuming fully diluted  
  earnings per share           177.9     165.5         177.0       163.4 (1)(4)
                            ========   =======      ========    ========        
 
                      
Earnings per share, assuming
  full dilution:
  Net Income                $    .19  $    .17      $    .57    $  (1.07)

Earnings per common share,
  as reported:
    Primary                 $    .17  $    .17      $    .54    $  (1.16)
                            ========  ========      ========    =========
    Fully diluted           $    .17  $    .16      $    .54    $  (1.16)
                            ========  ========      ========    =========


(1)   For the three and six months ended November 23, 1997 and November 24, 
1996, this calculation is submitted in accordance with Regulation S-K 
Item 601(b)(11) although it is contrary to paragraph 40 of the APB 
Opinion No. 15 because it produces an antidilutive result.

(2)  For the six months ended November 24, 1996, since the effect of using 
net loss for fully diluted earnings per share is antidilutive, 
primary and fully diluted earnings per share is calculated using net 
loss, as reported.

(3)  For purposes of this computation, all outstanding options and 
warrants on common stock are assumed to have been exercised, even 
though for the six months ended November 24, 1996, the related 
effects are antidilutive.

(4)   For the six months ended November 24, 1996, the effect of shares from 
the assumed exercise of all outstanding options and warrants and from 
the assumed conversion of convertible debt related to fully diluted 
earnings per share is antidilutive.  As a results, primary and fully 
diluted earnings per share is calculated using weighted average 
common shares outstanding.








14 of 22

1 of 22






<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          MAY-31-1998             MAY-31-1998
<PERIOD-END>                               NOV-23-1997             NOV-23-1997
<CASH>                                             734                     734
<SECURITIES>                                       119                     119
<RECEIVABLES>                                      336                     336
<ALLOWANCES>                                         0                       0
<INVENTORY>                                        246                     246
<CURRENT-ASSETS>                                  1699                    1699
<PP&E>                                            2754                    2754
<DEPRECIATION>                                    1166                    1166
<TOTAL-ASSETS>                                    3399                    3399
<CURRENT-LIABILITIES>                             1006                    1006
<BONDS>                                            306                     306
                                0                       0
                                          0                       0
<COMMON>                                            82                      82
<OTHER-SE>                                        1855                    1855
<TOTAL-LIABILITY-AND-EQUITY>                      3399                    3399
<SALES>                                            720                    1377
<TOTAL-REVENUES>                                   720                    1377
<CGS>                                              436                     833
<TOTAL-COSTS>                                      436                     833
<OTHER-EXPENSES>                                   121                     233
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 (3)                    (15)
<INCOME-PRETAX>                                     41                     122
<INCOME-TAX>                                        12                      30
<INCOME-CONTINUING>                                 29                      92
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                        29                      92
<EPS-PRIMARY>                                     0.17                    0.54
<EPS-DILUTED>                                     0.17                    0.54
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission